• Nachrichtendetail
• 

18.06.2024 14:05:04 - dpa-AFX: *LIGAND SAYS MERCK RECEIVES FDA APPROVAL FOR PNEUMOCOCCAL 21-VALENT CONJUGATE VACCINE FOR ADULTS

	Name	WKN	Börse	Kurs	Datum/Zeit	Diff.	Diff. %	Geld	Brief	Erster	Schluss
	MERCK CO. DL-,01	A0YD8Q	Frankfurt	116,400	08.07.24 08:04:11	+0,200	+0,17%	115,800	116,200	116,400	116,200
	LIGAND PHARMAC.NEW DL-001	A1C9RN	Frankfurt	77,500	08.07.24 09:06:37	+1,500	+1,97%	79,500	80,500	77,500	76,000